Esperion Therapeutics
ESPR
#7391
Rank
โ‚น31.03 B
Marketcap
โ‚น157.53
Share price
-1.62%
Change (1 day)
-27.23%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -โ‚น2.41 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are โ‚น0.29 Billion. In 2023 the company made an earning of -โ‚น13.01 Billion, an increase over its 2022 earnings that were of -โ‚น15.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น2.41 Billion-81.49%
2023 -โ‚น13.01 Billion-15.03%
2022 -โ‚น15.31 Billion-20.61%
2021 -โ‚น19.29 Billion84.28%
2020 -โ‚น10.47 Billion35.75%
2019 -โ‚น7.71 Billion-55.71%
2018 -โ‚น17.41 Billion19.57%
2017 -โ‚น14.56 Billion125.39%
2016 -โ‚น6.46 Billion51.43%
2015 -โ‚น4.27 Billion36.45%
2014 -โ‚น3.13 Billion43.55%
2013 -โ‚น2.18 Billion145.26%
2012 -โ‚น0.89 Billion
2002 -โ‚น2.54 Billion-7.81%
2001 -โ‚น2.75 Billion15.03%
2000 -โ‚น2.39 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น42.95 Billion 1,617.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น33.88 B-1,455.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น600.93 B-24,136.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น413.71 B-16,648.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น5.92 Billion 136.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น18.73 Billion 649.15%๐Ÿ‡บ๐Ÿ‡ธ USA